Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;7(2):415-422.
doi: 10.1002/ehf2.12595. Epub 2020 Feb 14.

Acute kidney injury in heart failure: a population study

Affiliations

Acute kidney injury in heart failure: a population study

Jose Luis Holgado et al. ESC Heart Fail. 2020 Apr.

Abstract

Aims: The objective of the present study is to assess the prognostic value of acute kidney injury (AKI) in the evolution of patients with heart failure (HF) using real-world data.

Methods and results: Patients with a diagnosis of HF and with serial measurements of renal function collected throughout the study period were included. Estimated glomerular filtration rate (GFR) was calculated with the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). AKI was defined when a sudden drop in creatinine with posterior recovery was recorded. According to the Risk, Injury, Failure, Loss, and End-Stage Renal Disease (RIFLE) scale, AKI severity was graded in three categories: risk [1.5-fold increase in serum creatinine (sCr)], injury (2.0-fold increase in sCr), and failure (3.0-fold increase in sCr or sCr > 4.0 mg/dL). AKI incidence and risk of hospitalization and mortality after the first episode were calculated by adjusting for potential confounders. A total of 30 529 patients with HF were included. During an average follow-up of 3.2 years, 5294 AKI episodes in 3970 patients (13.0%) and incidence of 3.3/100 HF patients/year were recorded. One episode was observed in 3161 (10.4%), two in 537 (1.8%), and three or more in 272 (0.9%). They were more frequent in women with diabetes and hypertension. The incidence increases across the GFR levels (Stages 1 to 4: risk 7.6%, 6.8%, 11.3%, and 12.5%; injury 2.1%, 2.0%, 3.3%, and 5.5%; and failure 0.9%, 0.6%. 1.4%, and 8.0%). A total of 3817 patients with acute HF admission were recorded during the follow-up, with incidence of 38.4/100 HF patients/year, 3101 (81.2%) patients without AKI, 545 (14.3%) patients with one episode, and 171 (4.5%) patients with two or more. The number of AKI episodes [one hazard ratio (HR) 1.05 (0.98-1.13); two or more HR 2.01 (1.79-2.25)] and severity [risk HR 1.05 (0.97-1.04); injury HR 1.41 (1.24-1.60); and failure HR 1.90 (1.64-2.20)] increases the risk of hospitalization. A total of 10 560 deaths were recorded, with incidence of 9.3/100 HF patients/year, 8951 (33.7%) of subjects without AKI episodes, 1180 (11.17%) of subjects with one episode, and 429 (4.06%) with two or more episodes. The number of episodes [one HR 1.05 (0.98-1.13); two or more HR 2.01 (1.79-2.25)] and severity [risk 1.05 confidence interval (CI) (0.97-1.14), injury 1.41 (CI 1.24-1.60), and failure 1.90 (CI 1.64-2.20)] increases mortality risk.

Conclusions: The study demonstrated the worse prognostic value of sudden renal function decline in HF patients and pointed to those with more future risk who require review of treatment and closer follow-up.

Keywords: Acute kidney injury; Heart failure; Renal function; Risk of hospitalization; Risk of mortality.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Risk to develop AKI episodes by CKD stage. Using as a reference the group in CKD Stage 1, the risk of risk (A) was HR 0.87 (95% CI 0.76–0.99) in Stage 2, HR 1.48 (95% CI 1.29–1.69) in Stage 3, and HR 1.95 (95% CI 1.65–2.30) in Stage 4. Injury (B) was HR 0.97 (95% CI 0.76–1.25) in Stage 2, HR 1.58 (95% CI 1.22–2.05) in Stage 3, and HR 3.49 (95% CI 2.61–4.66) in Stage 4. Failure (C) was HR 1.09 (95% CI 0.72–1.63) in Stage 2, HR 2.75 (95% CI 1.84–4.11) in Stage 3, and HR 16.36 (95% CI 10.84–24.69) in Stage 3. Lines: blue (Stage 1), orange (Stage 2), green (Stage 3), and red (Stage 4). AKI, acute kidney injury; CI, confidence interval; CKD, chronic kidney disease; HR, hazard ratio.
Figure 2
Figure 2
Percentage of patients with AKI severity episodes by CKD stage. AKI, acute kidney injury; CKD, chronic kidney disease.
Figure 3
Figure 3
Risk of AHF hospital admissions by AKI number (A), one‐episode HR 1.19 (1.09–1.31), two or more episodes HR 1.84 (1.57–2.15). Line colours: blue (no AKI), orange (one AKI), and red (two or more AKI). Severity (B) of AKI episodes risk 1.17 (1.06–1.3), injury 1.80 (1.54–2.1), and failure 1.38 (1.09–1.75). Line colours as in Figure 1. AHF, acute heart failure; AKI, acute kidney injury; HR, hazard ratio.
Figure 4
Figure 4
Risk of all‐cause mortality by AKI number (A) one‐episode HR 1.05 (0.98–1.13) and two or more episodes HR 2.01 (1.79–2.25). Line colours: blue (no AKI), orange (one AKI), and red (two or more AKI). Severity (B) of AKI episodes; HR for risk was 1.05 (95% CI 0.97–1.14), injury 1.41 (95% CI 1.24–1.60), and failure 1.90 (95% CI 1.64–2.20). Line colours as in Figure 1. AKI, acute kidney injury; HR, hazard ratio.

References

    1. Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 2016; 12: 610–623. - PubMed
    1. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta‐analysis. J Am Coll Cardiol 2006; 47: 1987–1996. - PubMed
    1. Takagi A, Iwama Y, Yamada A, Aihara K, Daida H. Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure. J Cardiol 2010; 55: 317–321. - PubMed
    1. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007; 13: 422–430. - PubMed
    1. Gansevoort RT, Correa‐Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339–352. - PubMed

Publication types